Big Pharma influencing medical schools, study

July 7, 2013

A new study released last week ranking Canadian medical schools “on the strength of their conflict-of-interest policies,” has determined that there are significant gaps in policies meant to “restrict the influence of the pharmaceutical industry.” Medical schools are supposed to limit the influence that a pharmaceutical company has on educational resources and course content, but the study found that at more than half of all schools, policies were either “permissive” or nonexistent in most categories. This is the second study to emerge recently about pharmaceutical industry influence on medical schools; in June the Toronto Star published an article suggesting a lecture series at uToronto was biased. Although some institutions are protesting the results, others suggested the study could be used to re-examine existing policies. Toronto Star